MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
7.70
+0.23
+3.08%
Opening 15:37 04/07 EDT
OPEN
6.86
PREV CLOSE
7.47
HIGH
8.14
LOW
6.71
VOLUME
2.18M
TURNOVER
--
52 WEEK HIGH
9.01
52 WEEK LOW
2.280
MARKET CAP
1.14B
P/E (TTM)
-7.1020
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADPT last week (0331-0404)?
Weekly Report · 10h ago
Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga · 3d ago
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 4d ago
Analysts Anticipate 27% Upside For The Holdings of VB
NASDAQ · 6d ago
Is Bio-Techne Corporation Stock Underperforming the S&P 500?
Barchart · 6d ago
Even though Adaptive Biotechnologies (NASDAQ:ADPT) has lost US$147m market cap in last 7 days, shareholders are still up 147% over 1 year
Simply Wall St · 03/31 17:40
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)
TipRanks · 03/31 10:50
More
About ADPT
More
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. It applies its platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across its two business segments: Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic test, offered to clinicians. The IM business focuses on the discovery and development of transformative immune-based therapies in the treatment of patients with cancer and autoimmune diseases.
Recently
Symbol
Price
%Change

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.